Business Daily Media

CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)

  • Written by Newsfile

Treating you—and your story—with courtesy and care.

Our commitment to delivering the best personal service defines our business and inspires our efforts every day. We’re accessible and responsive to every client we serve, using cutting-edge technology and innovation makes it easier for us to focus on relationship building. The way we see it, a helpful voice on the phone is always welcomed.

In addition to respecting you, Newsfile is respected as an accredited source of business news—making every story we handle become trusted for retail and institutional investment decisions.

Complete the form to the right and a customer service representative will contact you to answer your questions.

Read more https://www.newsfilecorp.com/release/213005/CSE-Bulletin-Delist-Canntab-Therapeutics-Limited-PILL